I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Jonathan N. Priantti
8
results:
Search for persons
X
Format
Online (8)
Mediatypes
Articles (Online) (5)
OpenAccess-fulltext (3)
Sorted by: Relevance
Sorted by: Year
?
1
Efficacy and safety of BRAF/MEK inhibitors in BRAFV600E-mut..:
Priantti, Jonathan N.
;
Rodrigues, Natasha Maranhão Vieira
;
de Moraes, Francisco Cezar Aquino
...
Endocrine. , 2024
Link:
https://doi.org/10.1007/..
?
2
Neurocognitive Adverse Events Related to Lorlatinib in Non-..:
Priantti, Jonathan N.
;
Vilbert, Maysa
;
de Moraes, Francisco Cezar Aquino
...
Cancers. 16 (2024) 14 - p. 2611 , 2024
Link:
https://doi.org/10.3390/..
?
3
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Thera..:
Moraes, Francisco Cezar Aquino de
;
de Oliveira Almeida, Gustavo
;
Alves, Vinícius Freire Costa
...
Journal of Personalized Medicine. 14 (2024) 5 - p. 464 , 2024
Link:
https://doi.org/10.3390/..
?
4
Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors..:
Priantti, Jonathan N.
;
Vilbert, Maysa
;
Madeira, Thiago
...
Cancers. 15 (2023) 15 - p. 3754 , 2023
Link:
https://doi.org/10.3390/..
?
5
Mesenchymal–Epithelial Transition Kinase Inhibitor Therapy ..:
Moraes, Francisco Cezar Aquino de
;
Vilbert, Maysa
;
Alves, Vinícius Freire Costa
...
International Journal of Molecular Sciences. 24 (2023) 24 - p. 17582 , 2023
Link:
https://doi.org/10.3390/..
?
6
Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors..:
Jonathan N. Priantti
;
Maysa Vilbert
;
Thiago Madeira
...
https://www.mdpi.com/2072-6694/15/15/3754. , 2023
Link:
https://doi.org/10.3390/..
?
7
Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors..:
Jonathan N. Priantti
;
Maysa Vilbert
;
Thiago Madeira
...
https://dx.doi.org/10.3390/cancers15153754. , 2023
Link:
https://doi.org/10.3390/..
?
8
Mesenchymal–Epithelial Transition Kinase Inhibitor Therapy ..:
Francisco Cezar Aquino de Moraes
;
Maysa Vilbert
;
Vinícius Freire Costa Alves
...
https://www.mdpi.com/1422-0067/24/24/17582. , 2023
Link:
https://doi.org/10.3390/..
1-8